Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case – control study

Summary We report 13 cases of presumed rocuronium-induced anaphylaxis in which sugammadex was administered with the intention of reversing the immunological reaction. Of these 13 cases, eight (62%) were later con fi rmed to be type-1 hypersensitivity reactions to rocuronium, three (23%) were triggered by an antibiotic and two (15%) were non-immunologically mediated. Response to treatment was scored by the treating anaesthetist, and compared with haemodynamic and inotrope measurements from the resuscitation and anaesthetic records. Haemodynamic improvement was seen in only six (46%) cases, three of which were associated with a non-rocuronium trigger. Of the three cases in which the treating anaesthetist thought that sugammadex had been bene fi cial, one was not caused by rocuronium, one had no improvement in blood pressure and one required 8.5 times as much adrenaline in boluses after, compared with the period before, sugammadex administration. These data suggest that sugammadex does not modify the clinical course of a suspected hypersensitivity reaction. .................................................................................................................................................................

[1]  P. Platt,et al.  Survival from perioperative anaphylaxis in Western Australia 2000-2009. , 2013, British journal of anaesthesia.

[2]  C. Meistelman,et al.  Slow recovery after sugammadex bolus after rocuronium-induced anaphylaxis. , 2014, British journal of anaesthesia.

[3]  B. Plaud A new option for the treatment of anaphylaxis linked to steroidal neuromuscular blockers: How much value should we grant to case reports? , 2014, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[4]  B. Debaene,et al.  Reversal of a rocuronium-induced grade IV anaphylaxis via early injection of a large dose of sugammadex , 2014, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[5]  P. Platt,et al.  Intraoperative Anaphylaxis to Sugammadex and a Protocol for Intradermal Skin Testing , 2014, Anaesthesia and intensive care.

[6]  P. Platt,et al.  Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. , 2013, British journal of anaesthesia.

[7]  P. Platt,et al.  Sugammadex, rocuronium and mast cell numbers in the rat liver , 2013, Anaesthesia.

[8]  A. Cunningham Anaphylaxis to Neuromuscular Blocking Drugs: Incidence and Cross-Reactivity in Western Australia , 2013 .

[9]  P. Platt,et al.  Survival from perioperative anaphylaxis in Western Australia , 2013 .

[10]  P. Diemunsch,et al.  Sugammadex in rocuronium anaphylaxis: dose matters. , 2012, British journal of anaesthesia.

[11]  B. Erdivanlı,et al.  Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver , 2012, Anaesthesia.

[12]  P. Platt,et al.  The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model * , 2012, Anaesthesia.

[13]  T. Yatabe,et al.  Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. , 2012, Journal of clinical anesthesia.

[14]  H. Dupont,et al.  [A case of rocuronium-induced anaphylactic shock, improved by sugammadex]. , 2012, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[15]  A. Funnell,et al.  A further case of rocuronium-induced anaphylaxis treated with sugammadex. , 2011, British journal of anaesthesia.

[16]  D. Ebo,et al.  Rocuronium‐induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment , 2011, Anaesthesia.

[17]  P. Platt,et al.  Quantification of Volume Loss and Haemodynamic Changes of Gelofusine®-induced Anaphylaxis during Cardiopulmonary Bypass , 2011, Anaesthesia and intensive care.

[18]  L. Green,et al.  Sugammadex in the management of rocuronium-induced anaphylaxis. , 2011, British journal of anaesthesia.

[19]  Simon G. A. Brown,et al.  Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis , 2005, Current opinion in allergy and clinical immunology.

[20]  F. Alla,et al.  Anaphylactic and Anaphylactoid Reactions Occurring during Anesthesia in France in 1999–2000 , 2003, Anesthesiology.

[21]  R. Pumphrey Fatal posture in anaphylactic shock. , 2003, The Journal of allergy and clinical immunology.

[22]  R. O’Connor,et al.  An evaluation of the pneumatic anti-shock garment (PASG) in various clinical settings. , 1997, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.